Shoulder arthroscopic and arthroplastic surgeries are associated with significant postoperative pain, which can delay recovery and increase opioid consumption. Interscalene blocks (ISBs) are a commonly used method to manage this pain, either as single-shot injections or continuous catheter infusions (CISBs). This review synthesizes findings from studies conducted in the past five years, comparing the efficacy, complications, and outcomes of single-shot ISBs versus CISBs for postoperative pain management in shoulder surgeries. Current literature highlights key differences: single-shot ISBs provide significant immediate postoperative pain relief, whereas CISBs offer prolonged analgesia beyond 48 hours, reduced opioid consumption, and enhanced recovery outcomes. However, CISBs carry a higher risk of complications and procedural complexity compared to single-shot ISBs. Both single-shot ISBs and CISBs present effective options for postoperative pain control in shoulder surgery patients. Single-shot ISBs may be preferable for patients seeking immediate pain relief with fewer complications, while CISBs are beneficial for those requiring prolonged analgesia. The choice of technique should be individualized based on the patient's needs, expected recovery, and potential risk factors.
Keywords: continuous interscalene block; opioid reduction; pain management; shoulder surgery; single-shot interscalene block.
Copyright © 2024, Karadimas et al.